Generation of the induced pluripotent stem cell (hiPSC) line (JUFMDOi004-A) from a patient with hearing loss carrying GJB2 (p.V37I) mutation

Stem Cell Res. 2020 Mar:43:101674. doi: 10.1016/j.scr.2019.101674. Epub 2019 Dec 4.

Abstract

The gap junction beta-2 (GJB2) gene is the most common genetic cause of hereditary deafness worldwide. Especially, V37I mutation in GJB2 is most prevalent in Southeast Asia including Thailand, Malaysia, and Indonesia. Furthermore, it is the second most prevalent cause in Japan and China, and exhibits an audiometric phenotype of mild-to-moderate hearing loss. In this study, we generated induced pluripotent stem cells (iPSC) from peripheral blood mononuclear cells (PBMCs) of patient with homozygous V37I mutation. This iPSC line will be a powerful tool for investigating the pathogenesis and for developing a treatment for GJB2-related hearing loss.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Connexin 26
  • Connexins / genetics*
  • Female
  • Hearing Loss / genetics*
  • Humans
  • Induced Pluripotent Stem Cells / metabolism*
  • Mutation

Substances

  • Connexins
  • GJB2 protein, human
  • Connexin 26